Compare MIND & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MIND | COCH |
|---|---|---|
| Founded | 1987 | 1995 |
| Country | United States | United States |
| Employees | 157 | 47 |
| Industry | Industrial Machinery/Components | Blank Checks |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.8M | 51.0M |
| IPO Year | N/A | N/A |
| Metric | MIND | COCH |
|---|---|---|
| Price | $5.02 | $0.71 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 79.1K | ★ 311.6K |
| Earning Date | 04-15-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $23.31 | $1.58 |
| Revenue Next Year | $1.01 | N/A |
| P/E Ratio | $22.27 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.66 | $0.36 |
| 52 Week High | $14.50 | $1.89 |
| Indicator | MIND | COCH |
|---|---|---|
| Relative Strength Index (RSI) | 44.46 | 51.93 |
| Support Level | $4.83 | $0.64 |
| Resistance Level | $9.19 | $0.74 |
| Average True Range (ATR) | 0.35 | 0.06 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 25.58 | 41.37 |
MIND Technology Inc provides technology and solutions for exploration, survey, and defense applications in oceanographic, hydrographic, defense, seismic, and security industries. The company operates in single segment namely, Seamap which provides services and products, including engineering, repairs and software licensing, utilized in marine exploration, marine survey and maritime security for marine survey companies, seismic survey contractors, research institutes, non-military government organizations and operators of port facilities and other offshore installations. The company generates more revenue from Seamap Marine Products. The company's geographical segments include the United States; China, Norway; Turkey; Singapore; and Canada & Other.
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.